The AI security controls healthcare and life sciences teams need must classify and govern sensitive data at the moment of AI interaction, so clinicians and researchers use approved AI tools with confidence instead of routing patient and research data through unsanctioned tools that create hidden protected health information (PHI) exposure. Security teams need discovery, inline data protection, vendor contracting controls, and continuous audit evidence. Aurascape governs AI use where it happens.

Last updated: August 2026.

Healthcare and life sciences (HLS) organizations handle some of the most sensitive data in any sector: PHI, genomic sequences, clinical trial records, and proprietary research. AI tools now touch all of it, from clinical documentation to drug-discovery pipelines. Solve this with blunt blocking and users find another tool. The ten controls below map to the four workflows HLS teams manage: clinical, research, operations, and engineering. Each control follows the same shape: what it is, why it matters, and where Aurascape fits.

1. Complete AI Discovery Across Clinical and Research Teams

AI discovery for healthcare means maintaining a live inventory of every AI app, account, and agent employees use, including tools security has not approved. You cannot set policy for approved, unapproved, and newly discovered AI use without that inventory first.

Why it matters: 82% of organizations have unknown AI agents and 61% reported data exposure from them (Cloud Security Alliance, 2026). In HLS, an unapproved summarizer processing a patient note becomes a regulated data handling issue, not just a productivity shortcut.

Where Aurascape fits: Aurascape continuously discovers the long tail of AI apps, embedded AI features, copilots, and agents across the network, endpoint, and API planes, and maintains a catalog of 30,000+ AI apps (Aurascape, 2026). HLS teams get a runtime inventory, not a periodic assessment. For a broader planning checklist, see the enterprise AI security controls checklist.

2. How to Control PHI and Sensitive Data in AI Prompts

Inline data classification means detecting PHI, genomic data, and research intellectual property inside a prompt, file upload, or AI response as it moves, not after the fact. Destination controls tell you where traffic goes. AI policy also needs the conversation content, the account context, and the action the user or agent is trying to take.

Why it matters: 43% of workers admit sharing sensitive workplace information with AI tools without their employer’s knowledge (National Cybersecurity Alliance, 2025). A clinician who pastes a note carrying a rare diagnosis can trigger re-identification risk even after routine de-identification steps.

Where Aurascape fits: Aurascape inspects the AI interaction inline and applies 600+ real-time data classifiers to prompts, files, code, and connector outputs (Aurascape, 2026). PHI and research data are caught wherever they move, and policy can redact or coach at the point of interaction instead of forcing a hard stop that pushes users to unsanctioned tools.

3. Context-Aware Policy with Coaching and Exception Workflows

Context-aware AI policy means enforcing outcomes based on the interaction itself: the content, the account type, the intent, and the action taken. Exception workflows and coaching give users an approved path when a task is legitimate but the data, account, or tool choice needs correction.

Why it matters: research teams move faster than policy approval cycles, especially when AI tools help with summarization, analysis, and code review. Only 38% of organizations have a formal, comprehensive AI policy even as 90% report employee AI use (ISACA, 2026). Coaching gives users a safe path without stopping the work.

Where Aurascape fits: at the interaction layer, Aurascape enforces policy in real time through allow, coach, notify, redact, redirect, block, capture, and require tenant actions (Aurascape, 2026). Using account type and conversation content as context, an HLS team can coach a researcher off a personal account, redact PHI inline, or redirect to an approved tool, and the workflow keeps moving.

4. Enterprise Tenant Enforcement and AI Vendor Contracting

Tenant enforcement and vendor contracting means requiring that AI use runs through the organization’s licensed enterprise account and that AI vendors handling PHI have appropriate agreements in place. Data handling terms differ between enterprise and personal accounts, and a permitted tool on a personal tenant can still create regulatory exposure.

Why it matters: Business Associate Agreements (BAAs) are required under HIPAA when a vendor processes PHI on behalf of a covered entity (HHS, 2025). BAA scope often depends on the product tier, contract, and enabled features, so personal AI accounts should not be approved for PHI workflows by default. AI vendor review should cover data retention terms, training data use, and breach notification obligations.

Where Aurascape fits: Aurascape distinguishes enterprise tenants from personal accounts and can require the enterprise tenant for approved apps as a policy action at the interaction layer (Aurascape, 2026). An approved tool used on a personal account gets caught and redirected, not silently permitted.

5. How Research and Clinical Teams Govern AI Agents

Agent tool-call governance means controlling the execution path an AI agent takes when it invokes a tool or retrieves data, not only observing that it happened. HLS teams must govern both human-to-AI use and the actions delegated agents take on a person’s behalf. Model Context Protocol (MCP) is one common tool-execution pattern, not the whole agent access-control problem.

Why it matters: OWASP ranks Excessive Agency among the top risks for AI applications (OWASP, 2025). An agent granted broad access in a research pipeline can act well beyond a single approved task, so the control is scoping and governing what a delegated agent may execute.

Where Aurascape fits: Aurascape discovers and secures local AI agents and their interactions, and adds a Zero-Bypass MCP Gateway (Aurascape, 2026) that marks every tool call it approves and blocks unmarked calls, governing the agent-to-tool execution path inline rather than observing it. See how HLS teams securely adopt AI agents.

6. Prompt Injection and Output Threat Prevention

AI threat prevention means detecting and stopping prompt injection, jailbreaks, tool poisoning, and unsafe outputs before they reach a user or a downstream clinical workflow. Prompt injection embeds malicious instructions in content a model processes, including documents, search results, or tool outputs.

Why it matters: EchoLeak (CVE-2025-32711) was a zero-click indirect prompt injection flaw in a widely used AI copilot (NVD, 2025). In a clinical context, a manipulated AI output can affect content a provider relies on for documentation or triage support.

Where Aurascape fits: at the interaction layer, Aurascape inspects prompts, responses, and tool results, stops prompt injection including instructions carried in tool results, and validates AI-generated content before it reaches users or downstream systems through Safe Output Governance (Aurascape, 2026).

7. Genomic, Research, and Proprietary Data Protection

Research data protection means classifying genomic sequences, clinical trial data, and proprietary research intellectual property inline so sensitive content is caught wherever it moves in a multi-step AI workflow. Generic identifiers are not enough. This work needs classifiers and policies that reflect genomic, clinical trial, and proprietary research workflows.

Why it matters: re-identifying a small genomic cohort can defeat de-identification assumptions, so data minimization and redaction cut what enters the AI interaction in the first place. An over-privileged research agent can read genomic records through one tool and send derived content through another. Each step looks normal until you review the full action chain.

Where Aurascape fits: Aurascape’s direction-aware classifiers inspect tool-call requests and results, and cross-call lineage makes a read-then-write chain across agent steps visible and interruptible (Aurascape, 2026).

8. Interaction-Level Audit Evidence

Interaction-level audit evidence means a decoded record of who used AI, on which account, what data was involved, and what policy decision occurred, captured as it happens. Audit trails assembled after the fact miss what happened inside the conversation, and the HIPAA Security Rule sets access control and audit control standards for information systems that handle electronic PHI (HHS, 2025). Confirm specific control mapping with your compliance and legal teams.

Why it matters: 97% of organizations that reported AI-related breaches lacked proper AI access controls (IBM, 2025).

Where Aurascape fits: Aurascape creates interaction records for audit and effectiveness, governed by role-based access control (RBAC) for privacy (Aurascape, 2026). Those records show the user, account, application, tool invoked, detected data category, and policy decision for an AI session, giving HLS compliance and audit teams evidence tied to specific access events.

9. Frictionless Governance for Distributed HLS Teams

Distributed AI governance means giving compliance officers, research leads, data owners, and legal teams role-based visibility into AI use without requiring access to a security console. Governance fails when policy ownership, data ownership, and compliance accountability sit only in a security silo.

Why it matters: the NIST AI Risk Management Framework organizes work into Govern, Map, Measure, and Manage functions and calls for accountability structures and policies across the organization (NIST, 2026). EU AI Act obligations for high-risk AI systems in clinical and regulated contexts include human oversight and record-keeping (EU AI Act, 2026). Confirm exact obligations with your compliance and legal teams.

Where Aurascape fits: Auri gives security, compliance, legal, and research owners role-based, natural-language access to AI usage, risk, and policy (Aurascape, 2026). Distributed HLS teams participate in policy within global security controls instead of waiting in a security team queue.

10. AI Validation and Risk Assessment for Regulated Processes

AI validation and risk assessment means evaluating AI systems the organization builds or deploys against intended use, failure modes, change control, and regulatory expectations before they touch regulated data. HLS engineering teams ship AI into clinical and research settings, not only consume commercial AI tools. Keep three activities distinct: clinical validation, security testing, and software change control.

Why it matters: FDA guidance for AI-enabled medical software emphasizes intended use, performance evidence, change management, and postmarket monitoring (FDA, 2025). AI-generated code in a regulated pipeline needs review before release.

Where Aurascape fits: for AI the organization builds, Aurascape runs pre-production assessment against prompt injection, jailbreak, unsafe output, and code-weakness scenarios before regulated data is introduced (Aurascape, 2026). See how HLS teams secure AI coding assistants. For AI that teams consume externally, Aurascape adds runtime controls at the AI interaction layer, including Safe Output Governance that validates AI-generated content before it reaches users or downstream systems.

Controls Mapped to HLS Workflows and Regulatory Touchpoints

Different HLS teams face different AI risks. This grid maps the four core workflows to the primary control each one needs and the relevant regulatory touchpoints. It is a planning map, not a compliance determination. CISO, compliance, research IT, and legal owners should use it together to assign ownership and confirm obligations with counsel.

Workflow	Primary AI risk	Core control	Regulatory touchpoint
Clinical	PHI in prompts and summaries	Inline PHI classification, coaching, redaction, BAA review	HIPAA Security Rule, BAA obligations
Research	Genomic and research IP exposure via agents	Agent tool-call governance, direction-aware classifiers	NIST AI RMF Govern and Map functions
Operations	Shadow AI on personal accounts	Discovery, enterprise tenant enforcement, vendor contracting	HIPAA BAA, EU AI Act transparency obligations
Engineering	Unvalidated AI-generated code in regulated pipelines	Pre-production assessment, code-weakness detection, output governance	FDA AI guidance, NIST AI RMF Measure and Manage functions

How to Roll Out These Controls

A phased rollout keeps clinical and research work moving while control tightens. A workable sequence:

1. Discover every AI app, account, and agent touching PHI, genomic data, and research records.
2. Inventory AI vendors and confirm BAA coverage for any tool that may process PHI.
3. Turn on inline classification for PHI, genomic data, and research intellectual property.
4. Start with coach and notify actions so researchers and clinicians learn without losing productivity.
5. Require enterprise tenants for approved tools and redact sensitive data by policy default.
6. Govern agent tool calls in research and clinical pipelines, blocking unmarked calls before execution.
7. Create interaction records for audit and give compliance, legal, and research owners role-based access.

How Aurascape Compares on HLS AI Controls

Secure web gateway (SWG) and data loss prevention (DLP) controls remain useful for HLS teams, and they extend web-era and SaaS-era controls into AI use. AI workflows also need interaction context, account-type context, and governed agent execution. This side-by-side comparison shows how Aurascape adds to the existing stack on the capabilities HLS teams need most.

Capability	SWG and DLP stack	Aurascape
Sensitive data detection	Content and pattern matching centered on destinations and file transfers	600+ real-time data classifiers applied inline to prompts, files, and tool calls
AI app coverage	Destination and category classification for known SaaS apps	30,000+ AI apps in a continuously updated catalog
Agent tool execution	Extends web and SaaS controls into AI traffic	Zero-Bypass MCP Gateway marks every approved tool call and blocks unmarked calls
Policy granularity	Destination-level allow or block	Eight actions: allow, coach, notify, redact, redirect, block, capture, require tenant
Audit evidence	Destination and transfer logs	Decoded interaction record showing user, data category, tool invoked, and policy decision

Frequently Asked Questions

What AI security controls do healthcare and life sciences teams need for regulated data?

HLS teams need controls that discover AI use, protect PHI and research data inline, govern agent actions, enforce approved accounts, and produce audit evidence. BAA review, validation for regulated processes, and distributed governance complete the operating model.

Do AI vendors need a BAA when PHI is processed?

Under HIPAA, a Business Associate Agreement is required when a vendor processes PHI on behalf of a covered entity. BAA scope often depends on the product tier, contract, and enabled features, so personal AI accounts should not be approved for PHI workflows by default. Review data retention terms, training data use, and breach notification obligations with legal counsel.

How should HLS teams validate AI in regulated workflows?

Keep clinical validation, security testing, and software change control as separate activities. Clinical validation documents intended use, performance evidence, and monitoring; security testing checks for prompt injection, jailbreak, unsafe output, and known code vulnerabilities; change control tracks model and code updates. For AI-enabled medical software, FDA guidance emphasizes intended use, performance evidence, change management, and postmarket monitoring. Confirm current obligations with your regulatory affairs team.

How do NIST AI RMF and EU AI Act apply to HLS AI use?

The NIST AI Risk Management Framework organizes work into Govern, Map, Measure, and Manage functions and calls for accountability structures across the AI lifecycle. EU AI Act obligations for high-risk AI systems in clinical and regulated contexts include human oversight and record-keeping. Both call for governance and evidence that security controls alone do not produce. Confirm specific obligations with your compliance and legal teams.

How do you stop researchers from routing PHI into unsanctioned AI tools?

Discover the tools they already use, classify sensitive data inline, and coach users toward approved tools instead of hard-blocking them. Give researchers an approved enterprise account and an easy exception path, and legitimate work keeps moving, which is what prevents workarounds.

What is the risk of over-privileged AI agents in research pipelines?

A broadly scoped agent can take actions well beyond a single approved task, and derived research data can move across tool boundaries. Scoping what a delegated agent may execute, governing the tool-call path, and keeping cross-call lineage make the full action chain reviewable before data leaves the governed environment.

Does Aurascape replace the existing security stack?

No. Aurascape is an additive layer that works alongside existing secure access service edge (SASE), cloud access security broker (CASB), SWG, and DLP tools. It adds controls for the AI interaction layer: conversation context, sensitive data classification, account context, and governed agent execution.

Can compliance and research leads access AI usage data without a security console?

Yes. Auri gives compliance, legal, and research owners role-based, natural-language access to AI usage, risk, and policy, so those teams participate in governance without a security console or query language.

---

Aurascape gives healthcare and life sciences teams the AI security controls to protect PHI, genomic data, and research intellectual property at the moment of AI interaction, so clinicians and researchers use approved AI tools confidently within the accountability structures HIPAA, NIST AI RMF, and EU AI Act governance require.

See how Aurascape secures AI for healthcare and life sciences →